Search Tag: Cancer

IMAGING Management

Screening for Lung Cancer

2013 27 May

A recently published article in the New England Journal of Medicine  describe the screening, diagnosis, and limited treatment results from the initial round of screening in the National Lung Cancer Screening Programme in the United States. Participants with at least 30 pack-years of smoking and asymptomatic were randomly assigned to undergo annual... Read more

IMAGING Management

CT Scans in Childhood and Adolescence Do Increase Cancer Risk

2013 24 May

Young people who undergo CT scans are 24 percent more likely to develop cancer compared with those who do not, a study published on suggests. 

However, the absolute excess for all cancers combined was low, at 9.38 for every 100,000 person years of follow-up.  The increasing use of CT scans has brought concerns about possible cancer risks,... Read more

Executive Health Management

International Study Closes in on Cancer Risk Markers

2013 22 May

Cancer research has taken a huge leap forward with scientists now able to identify more than 80 genetic markers found to increase the risk of breast, ovarian and prostate cancer.  The COGS international research initiative is believed to be the largest of its kind. 

Although the results have been widely reported, the cross-border efforts behind... Read more

IMAGING Management

Microwave Imaging Can Monitor Treatment

2013 13 May

Microwave imaging can be used to monitor how well treatment for breast cancer is working, finds new research published in BioMed Central’s open access journal Breast Cancer Research. Microwave tomography, a low cost and repeatable technique, was able to distinguish between breast cancer, benign growths, and normal tissue. Eight women with breast... Read more

IMAGING Management

New USA Lung Cancer Screening Guidelines

2013 13 May

New guidelines from the American College of Chest Physicians (ACCP) recommend offering low-dose computed tomography (LDCT) scanning for lung cancer screening to people with a significant risk of lung cancer due to age and smoking history. 
The guidelines recommend offering LDCT scanning to individuals at high risk of developing lung cancer, as part... Read more

IMAGING Management

New Imaging Agent Enables Better Cancer Detection and Staging

2013 24 Apr

Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye is an effective agent in detecting and mapping cancers that have reached the lymph nodes. The radioactive dye, called Technetium Tc-99m tilmanocept, successfully identified cancerous lymph nodes and did a better job of marking cancers than the... Read more

IMAGING Management

Breast Cancer Screening: Time for a New Paradigm?

2013 18 Apr

Mammography, the gold standard of breast cancer screening, reduces breast cancer mortality, but has important limitations. Critics point to reduced sensitivity for women with dense breasts, a high rate of false positives leading to excessive biopsies, and concerns about long-term effects of repeated radiation.  The authors of a review published... Read more

IMAGING Management

Navidea Lymphoseek® Gains FDA Approval

2013 16 Apr

Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, has announced U.S. Food and Drug Administration (FDA) approval of Lymphoseek® (technetium Tc 99m tilmanocept) Injection, which is indicated for use in lymphatic mapping procedures to assist in the localisation of lymph nodes draining a primary... Read more

Executive Health Management

Advances in Molecular Testing Offer New Hope for Lung Cancer Patients

2013 04 Apr

The emergence of molecular diagnostic testing in lung cancer offers new hope for patients battling the number one cancer killer in the United States and abroad. Now, for the first time after a decade of biomarker testing in lung cancer, a uniform approach for testing for the EGFR mutation and ALK rearrangement along with the availability of targeted... Read more

Executive Health Management

New Abbott Test Helps Doctors Detect the Presence of Two Important Health Issues

2013 28 Mar

Abbot today announced that the ARCHITECT AFP test, which may help doctors detect serious birth defects and the progression of testicular cancer, received U.S. Food and Drug Administration (FDA) approval.  Biomarkers, such as alpha-fetoprotein (AFP), are substances in the body that physicians can measure to identify the progress of diseases or conditions... Read more